As the
title implies, the causative organism in the last post was Aspergillus terreus. Once the causative agent was identified, the
patient was prescribed natamycin and Voriconazole eyedrops in addition to his
other prescriptions for 10 days. Normally amphotericin B (AMB) is prescribed to
fungal infections, but Aspergillus
terreus has intrinsic resistance to this antibiotic. Triazoles show
promising treatment for Aspergillus
terreus infections. When the treatment regimen was completed, the patient
underwent a photo-therapeutic keratectomy (PTK) to remove dense corneal
scarring caused by this infection.
Infections
caused by this organism can be classified as invasive, saprophytic or allergic,
and can be involved in lung disease, allergic bronchopulmonary disease,
allergic sinusitis, cutaneous infections, invasive bronchopulmonary disease,
intradural spinal biopsy, nosocomial aspergillus peritonitis, and invasive
aspergillosis. It is a common cause of fungal infections in hematologic
(leukemia) malignant patients and solid-organ or hematopoietic stem-cell
transplants patients.
One
problem with identifying fungal infections is that identification tests for
them are not routinely performed in the hospital laboratory setting. The main
reasons for this are the small patient volumes and lack of technical competency
in the hospital lab to perform the tests. Often, these samples are sent and
processed at reference labs, which is how this patient’s sample was analyzed.
Below is
the reference to the article “Aspergillus
terreus Recovered from a Corneal Scraping”
Campbell Suzanna, Aspergillus terreus Recovered from a Corneal Scraping. ASCLS. Spring 2014 . 27: 67-71.
No comments:
Post a Comment